Literature DB >> 19205033

Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.

Carmen Chak-Lui Wong1, Chun-Ming Wong, Edmund Kwok-Kwan Tung, Kwan Man, Irene Oi-Lin Ng.   

Abstract

UNLABELLED: Deregulation of Rho family small guanosine triphosphatases has been implicated in human carcinogenesis. Rho-kinases are downstream effectors of Rho guanosine triphosphatases in the regulation of cytoskeletal reorganization and cell motility. However, their functions in human cancers remain elusive. In this study, we aimed to investigate the role of Rho-kinases in hepatocellular carcinoma (HCC) tumor progression and invasion. We first examined the expression of the two Rho-kinases (ROCK1 and ROCK2) in human HCC, and found that ROCK2 was frequently overexpressed in primary HCCs (22/41 [53.66%]). Clinico-pathological analysis revealed that overexpression of ROCK2 was significantly associated with the presence of tumor microsatellite formation (P = 0.005), suggesting that deregulation of ROCK2 may contribute to the intrahepatic metastasis of HCC. Consistently, we demonstrated that stable overexpression of ROCK2 significantly enhanced cell motility and invasiveness in HCC cells. Conversely, stable knockdown of ROCK2 by short hairpin RNA approach remarkably reduced HCC cell migration and invasion. Moreover, orthotopic liver xenograft models provided further support that stable knockdown of ROCK2 suppressed HCC invasion in vivo. Stable knockdown of ROCK2 in HCC cells significantly inhibited Golgi reorientation, myosin phosphatase phosphorylation, and formations of stress fibers, filopodia, and lamellipodia; these molecular and cellular events are crucial for cell motility and cancer invasion.
CONCLUSION: Our results indicate that ROCK2 was overexpressed in human HCCs, and this overexpression was associated with a more aggressive biological behavior. Our findings also demonstrate that ROCK2 played a significant role in regulating cytoskeletal events and contributed to the invasion of HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205033     DOI: 10.1002/hep.22836

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  60 in total

1.  MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.

Authors:  Felice Ho-Ching Tsang; Sandy Leung-Kuen Au; Lai Wei; Dorothy Ngo-Yin Fan; Joyce Man-Fong Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

2.  Noncanonical NOTCH signaling limits self-renewal of human epithelial and induced pluripotent stem cells through ROCK activation.

Authors:  Takashi Yugawa; Koichiro Nishino; Shin-Ichi Ohno; Tomomi Nakahara; Masatoshi Fujita; Naoki Goshima; Akihiro Umezawa; Tohru Kiyono
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

3.  Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer.

Authors:  Kai Huang; Rongfa Yuan; Kai Wang; Junwen Hu; Zixi Huang; Chen Yan; Wei Shen; Jianghua Shao
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

4.  Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events.

Authors:  Amanda P Struckhoff; Jason R Vitko; Manish K Rana; Carter T Davis; Kamau E Foderingham; Chi-Hsin Liu; Lyndsay Vanhoy-Rhodes; Steven Elliot; Yun Zhu; Matt Burow; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2010-01-05       Impact factor: 5.285

Review 5.  Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity.

Authors:  C Hahmann; T Schroeter
Journal:  Cell Mol Life Sci       Date:  2009-11-12       Impact factor: 9.261

6.  Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion.

Authors:  Manhua Li; Jing Ke; Qiuhong Wang; Hongyan Qian; Lei Yang; Xunlei Zhang; Jinzhang Xiao; Haifang Ding; Xiaohang Shan; Qingqing Liu; Ying Xiao; Bojun Bao; Hua Huang
Journal:  Clin Exp Med       Date:  2016-12-05       Impact factor: 3.984

7.  ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma.

Authors:  Zhi-Ming Wang; Dong-Sheng Yang; Jie Liu; Hong-Bo Liu; Ming Ye; Yu-Fei Zhang
Journal:  Tumour Biol       Date:  2015-10-14

8.  Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma.

Authors:  Deshui Jia; Ying Jing; Zhenfeng Zhang; Li Liu; Jie Ding; Fangyu Zhao; Chao Ge; Qifeng Wang; Taoyang Chen; Ming Yao; Jinjun Li; Jianren Gu; Xianghuo He
Journal:  Cell Res       Date:  2013-12-03       Impact factor: 25.617

9.  Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma.

Authors:  Junbo Zhang; Xue He; Yueying Ma; Yanli Liu; Huaiyin Shi; Weiwei Guo; Liangfa Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

10.  A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasion.

Authors:  Vijay Pralhad Kale; Jeremy A Hengst; Dhimant H Desai; Taryn E Dick; Katherine N Choe; Ashley L Colledge; Yoshinori Takahashi; Shen-Shu Sung; Shantu G Amin; Jong K Yun
Journal:  Cancer Lett       Date:  2014-08-27       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.